JPMorgan Downgrades HP Stock: What Investors Need to Know
JPMorgan cuts HP Inc. rating to Neutral as PC replacement cycle ends and growth challenges emerge.
Already have an account? Sign in.
JPMorgan cuts HP Inc. rating to Neutral as PC replacement cycle ends and growth challenges emerge.
Repare Therapeutics (RPTX) announces acquisition by XenoTherapeutics for $1.82/share plus contingent value rights, expected to close Q1 2026.
Barrick Mining explores splitting into separate North American and Africa-Asia entities.
FDA adds black box warning to Sarepta's (SRPT) Elevidys, limiting use to walking DMD patients after two deaths from liver failure. Stock rose 9% as investors relieved FDA maintained approval for walking patients rather than pulling drug completely.